Serving up this steaming pile of
Celebrity Gossip
Gay Politics
Gay News
and Pointless Bitchery
Since 1995

Hello and thank you for being a DL contributor. We are changing the login scheme for contributors for simpler login and to better support using multiple devices. Please click here to update your account with a username and password.

Hello. Some features on this site require registration. Please click here to register for free.

Hello and thank you for registering. Please complete the process by verifying your email address. If you can't find the email you can resend it here.

Hello. Some features on this site require a subscription. Please click here to get full access and no ads for $1.99 or less per month.

Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient

Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, it said on Monday, as it set the price for a single vial at $390.

The price for U.S. private insurance companies will be $520 per vial, the drugmaker said, which equates to $3,120 per patient for a treatment course using 6 vials of remdesivir.

This is below the $5,080 per course recommendation by U.S. drug pricing research group, the Institute for Clinical and Economic Review, last week.

Gilead has entered into an agreement with the U.S. Department of Health and Human Services (HHS), with the agency and states set to manage allocation to hospitals until the end of September.

HHS has secured more than 500,000 treatment courses of the drug for American hospitals through September, the agency said on Monday.

This represents 100% of Gilead's projected production for July of 94,200 treatment courses, 90% of production in August and September, in addition to an allocation for clinical trials, HHS said.

After this period, once supplies are less constrained, HHS will stop managing the allocation, Gilead said.

Remdesivir's price has been a topic of intense debate since the U.S. Food and Drug Administration approved its emergency use in some COVID-19 patients in May. Experts have said that Gilead would need to avoid the appearance of taking advantage of a health crisis for profits.

Wall Street analysts have said the antiviral drug could generate billions of dollars in revenue over the next couple of years if the pandemic continues.

Gilead has tied up with generic drugmakers based in India and Pakistan, including Cipla Ltd and Hetero Labs Ltd, to make and supply remdesivir in 127 developing countries.

Cipla's version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab's version is priced at 5,400 rupees.

Offsite Link
by Anonymousreply 14Last Wednesday at 5:20 AM

Blessed be the pill.

Offsite Link
by Anonymousreply 1Last Monday at 5:42 AM

Isn't it overpriced? The Indian version is muchh cheaper the article states.

by Anonymousreply 2Last Monday at 5:43 AM

Glad to know that they're not in it for the money.

*rolling my eyes*

So if you can't afford it, then you.... die?

by Anonymousreply 3Last Monday at 5:44 AM

Gilead is going to rue the day of being so fucking greedy. And they will have to lower the price in the face of the coming opposition and blowback.

by Anonymousreply 4Last Monday at 5:48 AM

Their CEO should be jailed, just like that other Big Pharma asshole who jacked up prices, and was sent to jail for it!

I forget his name, but his nickname was something "Bro."

by Anonymousreply 5Last Monday at 6:01 AM

I don't understand.

Does this serum actually work?

Why wasn't there bigger news about a "vaccine?"

by Anonymousreply 6Last Monday at 1:58 PM

WaPo says this about the pricing (notice that taxpayers funded some of the development costs of this drug)-

[quote] Gilead said it will have spent $1 billion to develop and manufacturer remdesivir by the end of 2020. Gilead invented the drug about 10 years ago when it was searching for treatments for hepatitis C but did not develop it. Later, the drug’s potential as an antiviral for emerging diseases was explored through a partnership with the government. Taxpayers spent at least $70 million developing the drug, according to advocates.

[quote] An independent analysis last week by the Institute for Clinical and Economic Review said Gilead could recover its costs by distributing the drug for as little as $1 to $60 per dose, or $100 to $160 per dose if all of the company’s 2020 costs are taken into account.

[quote] Under Monday’s pricing, Gilead set the price at $520 per dose in the United States and $390 per dose in other developed countries. Gilead said six doses are required, while the U.S. Department of Health and Human Services said it was using an average of 6.25 vials in its estimated costs for hospitals.

by Anonymousreply 7Last Monday at 2:03 PM

This is unethical and immoral.

Offsite Link
by Anonymousreply 8Last Wednesday at 5:01 AM

We had the same thing on our news tonight, R8.

So the world's supply is going to the wealthy in the US, and everyone else, including the not-wealthy the in the US, can go to hell. That's a song we're getting really tired of hearing, and I guess you are too.

by Anonymousreply 9Last Wednesday at 5:08 AM

“You can always count on the Americans to do the right thing, after they have exhausted all the other possibilities.”

― Winston Churchill

Offsite Link
by Anonymousreply 10Last Wednesday at 5:08 AM

While Samantha’s cure all was biting the dawg that had bitten her, across town I had to wonder: when push came to shove, deep down, we’re we all deplorables?

by Anonymousreply 11Last Wednesday at 5:14 AM

Medicaid expansion passes by the teeniest of margins in Oklahoma. Republicans fear it will bankrupt the state.

Offsite Link
by Anonymousreply 12Last Wednesday at 5:14 AM

Take out senior management and shoot the fuckers.

That'll put manners on the rest of 'em.


by Anonymousreply 13Last Wednesday at 5:16 AM

The joke is America can’t be arsed to do anything else but they horde the drug. What are they planning to do, pour it over the corpses in the street?

by Anonymousreply 14Last Wednesday at 5:20 AM
Need more help? Click Here.

Yes indeed, we too use "cookies." Don't you just LOVE clicking on these things on every single site you visit? I know we do! You can thank the EU parliament for making everyone in the world click on these pointless things while changing absolutely nothing. If you are interested you can take a look at our privacy/terms or if you just want to see the damn site without all this bureaucratic nonsense, click ACCEPT and we'll set a dreaded cookie to make it go away. Otherwise, you'll just have to find some other site for your pointless bitchery needs.


Become a contributor - post when you want with no ads!